Caroline Lamarche

Assistant Professor

Université de Montréal

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Caroline Lamarche is an Assistant Professor at Université de Montréal in Canada. Her research focuses on immunology, specifically in areas such as regulatory T-cell dysfunction, chimeric antigen receptors, and the impact of innate immunity on vaccine responses. Recent publications include studies on Tregs immunometabolism, implications for cell therapy, and outcomes related to SARS-CoV-2 in transplant recipients.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Rita S. Suri

CANADA

View details

Jonathan Maltzman

Associate Professor

Stanford University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Caroline Lamarche

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Highlights of 2024: Tregs immunometabolism and how to counter inflammatory niches

Regulatory T-cell dysfunction and its implication for cell therapy

Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion

Prevalence and Impact of BK Polyomavirus in the Ureters of Kidney Donors: Research Letter

Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis Patients

Fluid Collection after Kidney Transplantation

Chimeric Antigen Receptor Regulatory T Cell in Transplantation: The Future of Cell Therapy?

Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.

Cellular therapies in kidney transplantation.

Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.

Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.

Collaborators (2)

Rita S. Suri

Jonathan Maltzman

Make your next move.